Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen for Alcohol Abstinence in Cirrhosis
NCT00525252Phase 2Completed
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- Feb 2003
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in alcohol dependence comparing Baclofen with Placebo (2 arms). Primary endpoints: Total alcohol abstinence at 12 weeks and Cumulative abstinence duration at 12 weeks. Started Feb 2003; status: completed.
02
Drugs
baclofen
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00525252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00525252.